215 related articles for article (PubMed ID: 15795914)
1. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
[TBL] [Abstract][Full Text] [Related]
2. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS
Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738
[TBL] [Abstract][Full Text] [Related]
3. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study.
Scott MA; Gandhi MK; Jestice HK; Mahendra P; Bass G; Marcus RE
Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741
[TBL] [Abstract][Full Text] [Related]
4. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
[TBL] [Abstract][Full Text] [Related]
5. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.
Urbano-Ispizua A; García-Conde J; Brunet S; Hernández F; Sanz G; Petit J; Bargay J; Figuera A; Rovira M; Solano C; Ojeda E; de la Rubia J; Rozman C
Haematologica; 1997; 82(6):683-9. PubMed ID: 9499667
[TBL] [Abstract][Full Text] [Related]
6. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
[TBL] [Abstract][Full Text] [Related]
7. Chronic graft-versus-host disease in children and adolescents after bone marrow transplantation from HLA-matched donors.
Yumura-Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Nakano T; Nomura K; Nakano T; Park DY; Endo C; Nishiuchi R; Sawada A; Matsuda Y; Oota H; Yoshimoto T; Kawa-Ha K
Int J Hematol; 2000 Apr; 71(3):278-82. PubMed ID: 10846836
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of chronic graft-versus-host disease after unrelated-donor bone marrow transplantation. Kanazawa University Bone Marrow Transplant Team].
Takami A; Nakao S; Ueda M; Takamatsu H; Sugimori N; Yamazaki H; Miura H; Ito K; Yamaguchi M; Niki T
Rinsho Ketsueki; 1995 Jan; 36(1):6-11. PubMed ID: 7715080
[TBL] [Abstract][Full Text] [Related]
9. Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation.
Bennett C; Waters T; Stinson T; Almagor O; Pavletic Z; Tarantolo S; Bishop M
Bone Marrow Transplant; 1999 Sep; 24(5):555-60. PubMed ID: 10482942
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A and chronic graft versus host disease.
Bacigalupo A; Maiolino A; Van Lint MT; Occhini D; Gualandi F; Clavio M; Lamparelli T; Tong J; Marmon AM
Bone Marrow Transplant; 1990 Nov; 6(5):341-4. PubMed ID: 2291996
[TBL] [Abstract][Full Text] [Related]
11. Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation.
Horn TD; Zahurak ML; Atkins D; Solomon AR; Vogelsang GB
Arch Dermatol; 1997 Aug; 133(8):961-5. PubMed ID: 9267240
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Martin SJ; Audrain MA; Oksman F; Ecoiffier M; Attal M; Milpied N; Esnault VL
Bone Marrow Transplant; 1997 Jul; 20(1):45-8. PubMed ID: 9232255
[TBL] [Abstract][Full Text] [Related]
13. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.
Wakui M; Okamoto S; Ishida A; Kobayashi H; Watanabe R; Yajima T; Iwao Y; Hisamatsu T; Hibi T; Ikeda Y
Bone Marrow Transplant; 1999 Mar; 23(6):573-8. PubMed ID: 10217188
[TBL] [Abstract][Full Text] [Related]
15. An update of prognostic factors for allogeneic bone marrow transplantation in multiple myeloma using matched sibling donors. European Group for Blood and Marrow Transplantation.
Gahrton G; Tura S; Ljungman P; Bladé J; Cavo M; De Laurenzi A; Façon T; Gratwohl A; Michallet M; Nikoskelainen J
Stem Cells; 1995 Aug; 13 Suppl 2():122-5. PubMed ID: 8520500
[TBL] [Abstract][Full Text] [Related]
16. Proliferation of CD4+ lymphocytes in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Hashino S; Mori A; Kobayashi S; Tanaka J; Musashi M; Asaka M; Imamura M
Int J Hematol; 2000 Jun; 71(4):389-93. PubMed ID: 10905061
[TBL] [Abstract][Full Text] [Related]
17. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation.
Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Yamada S; Kanamaru A; Kakishita E
Bone Marrow Transplant; 1999 Nov; 24(9):1005-7. PubMed ID: 10556960
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of chronic graft-versus-host disease in patients after bone marrow transplantation from HLA-identical siblings].
Akatsuka Y; Tsuzuki S; Sugihara T; Minami S; Kodera Y; Hirabayashi N
Rinsho Ketsueki; 1993 Dec; 34(12):1517-24. PubMed ID: 8295325
[TBL] [Abstract][Full Text] [Related]
20. Chronic graft-versus-host disease: is there an alternative to the conventional treatment?
Gaziev D; Galimberti M; Lucarelli G; Polchi P
Bone Marrow Transplant; 2000 Apr; 25(7):689-96. PubMed ID: 10745252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]